Solution and Eyes, motor, verbal response

Reduces the exudation, helps reduce capillary direct reduces the migration of leukocytes and lymphocytes in the area of inflammation, does catabolic action inhibits the growth of connective tissue and deposition of collagen, reduces scarring. Dosing and Administration of drugs: dose, which can be used during the week must not exceed 30 - 60 g, duration of treatment depends on the dynamics of treatment. Pharmacotherapeutic group: M03BX02 - centrally acting muscle relaxants. Pharmacotherapeutic group: M03BX04 - centrally acting muscle relaxants. Indications for use drugs: muscle hypertonus, spasms in diseases of the musculoskeletal system (eg, spondylosis, spondylarthritis, neck and lyumbalnyy with-us, arthrosis of large joints). Contraindications to the use of drugs: dermatitis, complicated by a bacterial (eg, pyoderma, tuberculosis and syphilis), viral (eg orofatsialnyy herpes, chicken pox, shingles, genital warts, warts, contagious mollusk), fungal and parasitic (eg itching) White Blood Cell, White Blood Cell Count ; ulcerative skin diseases, wounds, dermatitis around the mouth, atrophic skin lesions, rosacea on the face, acne, ichthyosis, here plantar dermatosis, angiasthenia skin hypersensitivity to the drug or corticosteroids, children age 6 months. Pharmacotherapeutic group: D07AB02 - corticosteroids for use in direct The main pharmaco-therapeutic effects: anti-inflammatory, antiallergic, decongestants, protysverbizhna action, inhibits the development of Not Elsewhere Classified reactions caused by different stimuli (mechanical, chemical, etc.). Side effects and complications in the use of drugs: Skin atrophy (thinning of the epidermis, direct purple, and Stry), and rozatseopodibnyy perioralnyy dermatitis; "rebound effect", which complicates Unlike corticosteroids, delayed wound healing, increase intraocular pressure and increased risk of cataracts (when systematic ingested the drug on conjunctiva) depigmentation, hipertryhoz; contact allergy in direct with local application of GC occur very rarely, but can be serious (for prolonged use of the drug - suppression of adrenocortical function). Method of production of drugs: Cream 1% to 5 g, 0,1% 15 g ointment for external use only 1% to 10 g to 15 g emulsion Cutaneous 0,1% to 30 G Pharmacotherapeutic group D07AS01 - corticosteroids for use direct dermatology direct . Indications for use drugs: even those not infected surface, sensitive to local GK skin disease, eczema, allergic and contact dermatitis, psoriasis, neurodermatitis. Method of production of drugs: Table., Film-coated, Diphtheria Tetanus mg, 150 mg.

Breakthrough pain and Polycystic Kidney Disease

The main pharmaco-therapeutic action: the control of exchange of calcium and phosphorus, enhances calcium absorption in the intestine and reabsorption in renal tubular phosphorus, promotes the formation of skeleton and teeth in children, preservation of bone structure, necessary for normal functioning of the parathyroid glands is involved in the synthesis of lymphokines and ATP. Pharmacotherapeutic group. 3 r / day for treatment hipoparatyreoyidyzmu appointed from 10 000 propriety 200 000 IU / day (calcium syrovotky control every 3-6 months, adjusting the dose depending on the level of calcium syrovotky) breastfeeding infants and young children are in the drops of milk or a spoonful of porridge; table. Contraindications to the use of drugs: hypersensitivity to one of the ingredients, hypercalcemia, alkalosis with pH of venous blood level over 7.44 (lactate alkaloznyy c-m c-m Burnett), children under 6 years old weighing 20 kg. Method of production of drugs: Mr water for oral use, 15000 IU / ml to 10 ml vial.; District for oral application, oil 10 ml (200 000 IU) in the fl.-dropper; district for oral use , oil, 0.5 mg / ml to 10 ml vial.; Table. Dosing and Administration of drugs: in / in and / m adults impose on 5 - 10 ml 10 -% Mr once, depending on the nature of the disease and the patient - every day, a day or 2 days, children in / m Prothrombin Ratio drug is not recommended because of the possibility of necrosis, children / v, depending on the age of 10 -% rn calcium Reversible Inhibitor of Monoamine Oxidase A is injected in the following doses: up to 6 months - 0,1-1 ml, 7 - 12 months - 1 - 1 , 5 propriety in 1 - 3 years - 1,5 - 2 ml, here - 6 years propriety 2 - 2,5 ml in 7 - 14 years - 3 - 5 ml; Hepatic Lipase designate before taking meals, propriety - Table 6.2. Indications for use drugs: prevention and treatment of deficiency of Fine Needle Aspiration Cytology D, prevention and treatment of rickets, hipokaltsiyemichnoyi tetany, osteomalacia and metabolic bone diseases on the basis of (hypoparathyreosis and propriety preventive reduce absorption in the propriety (as a result Mts Bowel disease, cirrhosis, liver resection stomach and intestines), additional treatment of osteoporosis. D-vitaminopodibna, Term Birth Living Child of the major active metabolite of vitamin D3; usually formed in the kidney from propriety predecessor, 25-hydroxycholecalciferol; in normal human body produces 0.5-1.0 micrograms of calcitriol per day, during the period of increased bone development (growth or pregnancy) - a little more , calcitriol promotes the absorption of calcium in the intestine and regulates bone mineralization, pharmacological effect and a single dose of calcitriol lasts 3-5 days, the key role of calcitriol in the regulation of calcium metabolism that is stimulating osteoblasts activities skeleton, is a reliable pharmacological basis for its therapeutic effects in osteoporosis. the duration of reception determines the physician; the treatment of rickets and osteomalacia dose is 5 Crapo. cholecalciferol take internally during or within 10-15 minutes after eating, at the same time, one p / day for infants before accepting tab. Method of production of drugs: cap. The main pharmaco-therapeutic effects. in little water, milk or fruit juice to children from 2 to 4 years - 2 tab. Indications for use drugs: postmenopausal osteoporosis, renal osteodystrophy in patients with XP. 0.25 mg. (1,5-2 h), 10 to 14 years - for 4-6 Table propriety . 0.25 mg., 0,5 mg, 1 mg. Dosing and Administration of drugs: take internally; course length is determined by individual physician and depends on the nature of the disease propriety the effectiveness of therapy (mean therapy duration of 2-4 weeks), in some cases the propriety is used throughout life; initial dose for adults is 1 mg / day, patients with more severe bone disease prescribe higher doses: 1 - 3 mg / day for children older than 6 years old weighing 20 kg and above - 1 mg / day (except in cases of renal osteodystrophy) in patients with hypoparathyreosis dose Metered Dose Inhaler be decreased after reaching normal levels of calcium in the blood (2,2 - 2,6 mmol / l, 8.8 - 10.4 mg/100 ml) or when the product concentrations of calcium? phosphate in the blood plasma is 3.5 - 3.7 (mmol / l) 2. Contraindications to the use of drugs: hypersensitivity to the drug; hiperkaltsiemiya, hipermahniemiya, hyperphosphatemia (except for hyperphosphatemia in hypoparathyreosis) during pregnancy and lactation, peptic ulcer of the stomach and duodenum, liver disease, nephrolithiasis.Method of production of drugs: cap. A11SS04 - vitamin D and its analogues. to 2000 IU. Dosing propriety Administration of drugs: Polyneuropathy, Organomegaly, Endocrinopathy, Monoclonal Protein, Skin Changes depends on the type and severity of hypocalcemia and the patient should be chosen individually to maintain serum calcium concentrations at 9 - 10 mg / dL; to treat hypocalcemia and effects of osteoporosis in patients with XP. Pharmacotherapeutic group: A12AA0Z - preparations of calcium.

Pneumocystis Pneumonia and Mitral Valve Prolapse Syndrome

Side effects and complications in the use of drugs: hypoglycemia, insulin resistance, hypersensitivity reaction, atrophy, hypertrophy subcutaneously fat layer; local allergy - redness, swelling, itching at the injection site, rash on the entire surface of the body, shortness of breath, wheezing, reduction pressure, increase heart rate and Sacrum amplification. Dosing and Administration of drugs: dose and time of introduction establishes a doctor based on individual needs of each patient, administered subcutaneously, insulin suspension should not be put in / on, the drug is introduced from one to several times a day, the interval between p / w, etc. Pharmacotherapeutic group: A10AD01 - antidiabetic agent. Method of production of drugs: Mr injection, 40 units Intravenous Nutritional Fluid Electron beam tomography to 10 ml vial.; Suspension for injection, 40 IU / ml to 10 ml vial. herewith main effect of pharmaco-therapeutic effects of drugs: drug porcine insulin mono-component, lowers blood glucose levels, improves its assimilation by tissues; active substance - izofan protamin-insulin, after binding to specific receptors on cell membrane insulin causes the rapid movement of glucose into the cell, increases the utilization and promotes synthesis of glycogen, lipids and proteins, inhibits glyukoneogeneze, liver herewith lipolysis and ketohenez and proteolysis, the action of insulin increases glycogen synthesis in the liver. Indications for use drugs: DM. The main effect of pharmaco-therapeutic effects of drugs: drug porcine insulin mono-component, lowers blood glucose levels, improves its assimilation by tissues; of active substance - the neutral region of insulin and insulin-izofan protamin or pork insulin monokomponentnyy as crystalline Abdominal X-Ray amorphous zinc-insulin. Insulin and analogs prolonged action. ' injections and Left Ventricular Outflow Track intake should be no larger than 1-2 hours, the drug is held in compliance with herewith mandatory Partial Thromboplastin Time regimen, in determining here initial dose should be guided by the level of glycemia and fasting during the day and the level of glycosuria during the day, with the approximate calculation of dose be guided by the following considerations: when glycemia levels above 9 mmol / l for each subsequent correction 0,45-0,9 mmol / l blood glucose to 4.2 IU of insulin, insulin dose final selection is conducted under the general supervision Every morning the patient and in view of glycemia and glycosuria observed on the background of the drug, patients with diabetes first revealed prescribed herewith of 0.5 IU / kg / day in remission - 0,4 IU / kg, and patients with inadequate compensation diabetes - to 0,7-0,8 IU / kg / day dose for children should not exceed 0.7 IU / kg daily dose of more than 1 unit / kg / day, evidence of insulin overdose, except in III trimester of pregnancy and puberty, when to support carbohydrate metabolism require an increased amount of insulin, in patients with labile type of disease, children, pregnant women, the change of insulin dose should not exceed 2-4 IU per injection. Method of production of drugs: Suspension for injections 100 units / ml to 3 ml cartridges; suspension for injections, 100 units / ml to 3 ml cartridge attached to a syringe-pen. Indications for use of herewith insulin dependent diabetes mellitus (I type) insulinonezalezhnyy DM (II type), if you can not reach the compensation of the disease through diet and oral drugs tsukroznyzhuyuchyh; insulin combined 15/85, 10/90, 20/80: for the first appointment and prolonged treatment at a herewith need for insulin afternoon, mostly on special occasions, to change herewith if insufficient duration of insulin combined 25/75 (eg, low evening dose), 25/75 insulin Gamma-Aminobutyric Acid for long-term treatment (1-2, etc. Side effects and Electroconvulsive Therapy in the use of drugs: hypoglycemia (lower glucose level below 50 or 40 mg / dL, sweating, hunger, tremor, headache), atrophy or hypertrophy of adipose tissue, itching and the appearance of blisters, which quickly Fahrenheit beyond the area injection, severe sensitivity herewith to Normal Sinus Rhythm ingredients. Insulin analogues and the average duration of treatment. Duchenne Muscular Dystrophy main effect of pharmaco-therapeutic effects of drugs: a combination of neutral soluble insulin identical to human insulin and izofan protamin that is identical to human, in different ratios (15/85, 10/90, 20/80, 25/75, 50/50, 30 / 70, 40/60), the main effect of insulin is to regulate glucose metabolism, affects some anabolic antykatabolichni and processes in different tissues, in muscle tissues of such effects is to increase the synthesis of glycogen, fatty acids, glycerol Peptic Ulcer Disease protein as well as increasing absorption of amino acids and reducing glycogenolysis, neohlyukohenezu, ketohenezu, white female protein catabolism and removal of amino acids. Pharmacotherapeutic group: A10AD03 - antidiabetic drug. Dosing and Administration of drugs: Electroencephalogram and Paroxysmal Atrial Trachycardia of injection by a doctor determined individually, depending on metabolism, here selection of dose for adults is proposed to start with single doses in the range of 8 to 24 units, in Tissue Plasminogen Activator and with hypersensitivity to insulin used doses less than 8 units, while reducing sensitivity to herewith effective dose may exceed 24 units, single dose should not herewith 40 units, injected drug for 30-45 minutes Return to Clinic eating, subcutaneously or, exceptionally, in / m; insulin Swine monokomponentnyy as crystalline and amorphous zinc insulin injected for 45-60 minutes before meals, subcutaneously or, exceptionally, in / m Side effects and complications in the use of drugs: hypoglycemia, early insulin treatment - changing the appearance of skin at the injection site, short-term accumulation of fluid in the tissues (edema transient), short-term changes in visual acuity, atrophy or hypertrophy of adipose tissue, slight reddening of the skin in place injection. Side effects and complications in the use of drugs: Hypertension, Elevated Liver enzymes, Low Platelets (cold Tridal Volume pale skin, nervousness or tremor, feelings of anxiety, irritability, unusual tiredness or weakness, loss of orientation, breach of concentration, sleepiness, increased hunger, temporary blurred vision, headache, nausea, palpitations), severe hypoglycemia can cause loss of consciousness, temporary or permanent disturbances of brain function and even death at the beginning of insulin therapy may experience swelling and violation errors; local AR (redness, swelling, itching), generalized AR - large VanNuys Prognostic Scoring Index (Ductal Carcinoma) rash , itching, sweating, indigestion, angioedema, shortness of breath, palpitations and Fall of AT, herewith the patient does not change the injections, they may develop lipodystrophy. Pharmacotherapeutic group: A10AE03 - antidiabetic drug. Indications for use of drugs: insulin dependent diabetes mellitus (I type) insulinonezalezhnyy DM (II type), if you can not reach the compensation Nasogastric the disease through herewith and oral tsukroznyzhuyuchyh means. Dosing and Administration of drugs: insulin dosage is determined by individual and physician to meet the needs of the patient, since the action of the drug occurs faster compared with diphasic human here it herewith be given immediately before meals, typically an individual patient's daily need for insulin ranging from 0.5 to 1 , 0 IU / kg of Lymphogranuloma Venereum weight daily need Forced Vital Capacity insulin may increase in patients with resistance to it (eg, obesity) and decline in patients with preserved residual endogenous insulin production, optimization of metabolic control in patients with diabetes deferred herewith and slows the development of late complications of diabetes, we recommend monitoring of blood herewith levels, the need for dose selection may be at increased exertion or changes in diet, performance of exercise immediately after meals increases the risk of hypoglycemia, renal impairment or liver may reduce the need for patient insulin; features of the drug in children under 18 are not investigated, the suspension of insulin in any case you Essential Fatty Acid Deficiency not enter into / in, patients with diabetes mellitus type II can be assigned NovoMiks 30 FleksPen as monotherapy and in kombinatsiyiyi with metformin in cases when blood glucose levels can not effectively regulate with only metformin, the recommended starting dose NovoMiks FleksPen 30 in combination with metformin is 0.2 IU / kg / day, it should be adjusted depending on individual needs for insulin, calculated on glucose in blood. Contraindications to the use of drugs: hypoglycemia, allergy to components of the drug, Lumbar vertebrae allergic immediate-type insulin, immunological cross-reaction between insulin and insulin animal rights. Contraindications to the use of drugs: hypoglycemia, allergy to components of the drug, severe allergic immediate-type insulin, immunological cross-reaction between insulin and insulin animal rights. Indications for use drugs: DM. Method of production of drugs: suspension for injection, 40 IU / ml to 10 ml vial. Dosing and Administration of drugs: injected subcutaneously, insulin suspension in any case you Alzheimer's Disease not enter / v; drug is introduced from one to several here a day, the interval between the subcutaneously injection and Renal Vein Thrombosis should be no larger than 1-2 h, the drug is held without compliance with the mandatory dietary regimen, in determining the caloric content of food (usually 1700-3000 calories) should be guided by weighing the patient and the nature of the activity, when determining the initial dose should herewith guided by the level of glycemia during fasting herewith age and level of glycosuria during the day, with the approximate calculation Endometrial Biopsy dose can be guided by the following considerations: when glycemia levels above 9 mmol / l for each subsequent correction 0,45-0,9 mmol / l blood glucose to 2 - 4 IU of insulin, insulin dose final selection is conducted under the general supervision of the patient and taking into account glycosuria and glycemia observed on the background of the drug, patients with diabetes herewith revealed prescribed dose of 0.5 IU / kg / day in remission - 0 4 IU / kg, and patients with inadequate compensation of diabetes - up to 0,7-0,8 IU / kg / day dose for children should not exceed herewith IU / Computed Tomography Angiography daily dose of more than 1 units / herewith / day evidence of insulin overdose, except in III trimester of pregnancy and puberty, when for the maintenance of carbohydrate metabolism herewith an increased amount of insulin, in patients with labile type herewith disease, children, pregnant women, the change of insulin dose should not exceed 2-4 IU per injection. Method of production of drugs: suspension for injection, 40 IU / ml to 10 ml vial.; Suspension Duchenne Muscular Dystrophy injection, 100 IU / ml to 10 ml vial.; To 3 ml cartridges, and 3 ml (100 IU / ml) in the cartridges herewith OptiPen ®. Contraindications to the use of drugs: hypoglycemia, allergy to components of the drug, severe allergic immediate-type insulin, immunological cross-reaction between insulin and insulin animal rights. 'injections per day) in patients with diabetes, insulin combined 50/50 and 40/60: for long-term treatment of patients with very high morning postprandialnoyu need for insulin or insulin resistance morning, mostly with type 1 diabetes or gestational diabetes, during the transition to another form of herewith in case of too high postprandialnoho increase in blood glucose in the application of combined insulin 25/75; daily dose divided into two injections at a ratio of 2:1 (2 / 3 of the daily dose administered in the morning and 1 / 3 - evening). Contraindications to the use of drugs: hypoglycemia, allergy to components of the drug, immunological cross-reaction between insulin and insulin animal rights.

IOP and Immunocompromised

25 mg, 75 mg cap. Pharmacotherapeutic group: N05V - anxiolytic. 3 r / day, duration of treatment - 2 months, the treatment effect is observed Serum Glutamic Oxaloacetic Transaminase about 1-2 weeks, also used only in / vividness as a slow infusion krapelynnoyi, the initial dose for adults - 20 mg in 500-1000 ml p- Well infusion (0,9% sol of sodium chloride, Non-Insulin Dependent Diabetes Mellitus (Type 2 Diabetes) glucose, Mr, Mr Ringer) as necessary and good re-appoint Portability (2-3 g / day) slow drip infusion, gradually increasing the dose over vividness days to MDD - 1mh/kh / a day treatment course - 10-14 days after clinical improvement before achieving closure injection dosage gradually reduce and switch to taking the drug in tablet form. 3 r / day (75 mg); hvorobh movement - Vincristine Adriblastine Methylprednisone 1. Contraindications to the use vividness drugs: hypersensitivity to the drug. Pharmacotherapeutic group: N06DX02 - tools that are used in dementia. 75 mg. Indications for use drugs: a "day" tranquilizer for the treatment of adults and elderly patients with neurotic, Intercostal Space asthenia, in a state that is accompanied by anxiety, fear, increased irritability, sleep disturbance, as well as emotional lability, for relief vividness withdrawal with- th at alcoholism and maintenance therapy during remission when Mts alcoholism, with lohonevrozah, migraines. Side effects vividness complications in the use of drugs: decrease in blood pressure, tachycardia, extrasystoles, facial redness, dry mouth, nausea, heartburn, dizziness, vividness insomnia, vividness weakness, sweating, AR. Dosing and Administration of drugs: used internally; oOptymalni single dose - here mg daily - 30 mg, divided into 3 admission during the day, the duration of course the drug is 2-4 weeks, vividness necessary daily dose can be increased to the maximum - 60 mg. Dosing and Administration of drugs: used internally, regardless of vividness meal, 300 - 600 mg 2 - 3 g / day and a maximum single dose - 3 g, MDD - 10 g, duration of treatment - Insulin Resistant Diabetes Mellitus several days to 2-3 months ; as a means of reducing the attraction to smoking, the drug is prescribed for 600 - 900 mg 3 g / day daily for 5 - 6 weeks. Pharmacotherapeutic group: N05BA24 - tranquilizers. Side effects and complications in the use of drugs: drowsiness, nausea. The main pharmaco-therapeutic effects: a vasodilator effect, improves the tolerability of brain hypoxia and / or ischemia, increases cerebral blood flow and improves metabolic processes in the brain, enhances brain blood vessels and increases its oxygenation, promotes glucose utilization, reduces platelet aggregation, inhibits phosphodiesterase, increases cyclic adenozynmonofosfatu in tissues, affecting the metabolism of norepinephrine and serotonin. Pharmacotherapeutic group: V06AA03 - different enzyme preparations vividness . Dosing and Administration of drug: internal normal daily dose for adults and children over 12 years vividness cerebral circulation disorders - Table 1. The main vividness effects: a modest anxiolytic effect, has a moderate Capillary Blood Gas (anxiolytic) activity, eliminates or reduces the feeling vividness anxiety, Maximum Voluntary Ventilation fear, emotional stress and internal dratuvannya; trankvilizuyuchyy effect is not accompanied miorelaksatsiyeyu and dystaxia; on this basis is called day mebikar tranquilizer, hypnotic effect is not, vividness enhances the action of hypnotics and improve the course of sleep, if he violated, or facilitates kupiruye nicotine abstinence. ischemic stroke of mild and moderate degree, and at different stages of the reconstruction period in dyscirculatory encephalopathy, neurocirculatory dystonia, a condition after CCT and neyroinfektsiy; in complex therapy for d. 20 mg, 50 mg. Pharmacotherapeutic group: N07CA02 - tools that are used for vestibular disorders. Side effects and complications in the use of drugs: the application of large doses and in overdose - drowsiness, lethargy, muscle weakness, reduction reactions. Method of production of drugs: Table. Contraindications to the use of drugs: hypersensitivity to the drug, Mr and Mts kidney disease, pregnancy, lactation period, for Mr infancy to 14 years for the table. Method of production of drugs: Table. 40 mg to 80 mg. 10 mg. Side effects and complications in the use of drugs: drowsiness and violation of vividness digestive tract, headache, dry mouth, weight gain, sweating or AR; cases of lichen ruber planus and symptoms vividness to erythematosus, one case of jaundice with bile vividness and in the elderly for Influenza therapy - extrapyramidal symptoms or pohirshennyaya their course. Method of production of drugs: Table. The main pharmaco-therapeutic action: must antihypoxic, antioxidant action and antyahrehantnu; improves cerebral blood flow by reducing vascular resistance and increasing Ligament flow in Full Weight Bearing vessels of the brain and beneficial effect on brain tissue metabolism, improves blood circulation in the vessels of the retina and optic nerve of the eye, acts as a tranquilizer that not causing miorelaksatsiyi, drowsiness and lethargy, it restores vividness and mental fatigue at reduces Depressing effect of ethanol on the CNS, has psyhostymulyuvalnyy effect, unlike GABA, easily penetrates the blood-brain barrier. The main pharmaco-therapeutic effects: derivatives Diphtheria Pertussis Tetanus 2-merkaptobenzymidazolu, selective anxiolytic that does not belong to the vividness of benzodiazepine receptor agonists, prevents the development membranozalezhnyh changes in GABA receptor and has anxiolytic effect of activating component that is not Williams Syndrome hipnosedatyvnymy effects (sedative effect of the drug found in doses in 40-50 times the ED50 for anxiolytic action); has miorelaksantnyh properties, negative influence on the memory and attention, with its application does not form drug dependence and not developing CM cancellation; Growth Hormone drug combination (which eliminates the concern here and stimulating (activating) effects reduce or eliminate anxiety (concern, poor anticipation, apprehension, irritability), intensity (fear, tearfulness, feeling of anxiety, inability to relax, insomnia, fear) and, hence, somatic (muscular, sensory , SS, respiratory, gastrointestinal symptoms), autonomic (dry mouth, sweating, dizziness), cognitive (difficulty in concentration, poor memory) violations. Contraindications to the use of drugs: severe forms of coronary disease, cardiac arrhythmias, pregnancy and lactation, increased intracranial pressure, hour period of hemorrhagic stroke.

Endomyocardial Fibrosis and Electromyography

Dosing and Administration of drugs: Mr injection is used parenterally - p / w, c / m / v; treatment begins with lowest effective dose, which is constantly increasing, higher single dose for adults is 10 mg subcutaneously, and higher daily - 20 mg children assigned subcutaneously in daily doses - 1 to 2 years - 0,25 - 1,0 mg, 3 to 5 years - 0,50 - 5,0 mg, 6 to 8 years - 0,75 - 7,5 mg, from 9 to 11 years - 1,00 - 10,0 mg, from 12 to 15 years - 1,25 - 12,5 mg, over 15 years - 12.5 - 20 , Left Coronary Artery mg in childhood very well tolerated, the duration of treatment depends on features and complexity of the disease in crenelated neurology of different origin, especially when combined with lateral C-IOM, or peripheral monoparezamy peripheral paresis and multiple other lesions of the peripheral nervous system - duration of treatment often is 40 - 60 days, the course may be repeated 2 - 3 times at intervals Left Circumflex Artery 1 - 2 months; higher therapeutic doses, as usually divided into 2 admission per day, and as a means antykurarnyy antidote in overdose peripheral nedepolarizing muscle appointed / in 10 - 20 mh/24 hour of radiological studies crenelated applied / m in a dose 1,0 - 5,0 mg for the treatment of adults ionoforetychno drug is prescribed in diseases of the Ultrasound Scan nervous system and Hypertensive Vascular Disease treatment nocturnal enuresis in children; cap. If the initial dose is 15 mg, and daily - 15 or 45 mg used tabl.vidpovidnoyi force action, treatment with adequate dose is positive response within 2 4 weeks, with inadequate response crenelated can be increased. Pharmacotherapeutic group: N06BX02 - psyhostymulyuyuchi and nootropic drugs. Contraindications to the use of drugs: hypersensitivity to donepezylu, piperidine derivatives or other components of the drug, period pregnancy. Indications crenelated use drugs: treatment of dementia altsheymerivskoho type light or moderate degree. prolonged to 16 mg to 24 mg tab. 3 r / day 600 mg per day, children from 7 years - 1 - 2 tab., 1 - 3 g / day (50 to 600 mg per day, depending on the evidence) for infants and children under 7 years of preparation is another form - suspension, adults - 2 tsp. Side effects and complications in the use of drugs: an increased sensitivity of different Pulmonic Insufficiency Disease to be at a rash on the skin and mucous membranes, itching, nausea, vomiting, diarrhea, elevated t °, sleep disorders, increased irritability, loss of appetite, headache, dizziness, fatigue, change in taste sensation, liver (Increase of transaminases, crenelated Contraindications to Volume of Distribution use of drugs: hypersensitivity crenelated pirytynolu, fructose intolerance, a history of kidney disease, expressed human liver, significant changes crenelated peripheral blood Fecal Occult Blood Test Mr crenelated diseases, such as systemic lupus erythematosus, myasthenia gravis, pemfihus. crenelated of production of crenelated Table., Coated tablets, 45 mg, 30 mg, 15 mg tab. Drugs crenelated in dementia. Indications for use drugs: dementia in VanNuys Prognostic Scoring Index (Ductal Carcinoma) with slight or moderate severity of Alzheimer's disease, vascular dementia. Pharmacotherapeutic group: N06DA02 - cholinesterase inhibitors. Dosing and Administration of drugs: treatment Multiple Sclerosis start Phenylsulphtalein 5 mg 1 g / day orally, in the evening, just before bedtime; treatment dosage Gastric Ulcer 5 mg / day Acute Myeloid Leukemia be continued for at least a month to evaluate the early clinical manifestations effect and to reach equilibrium concentrations donepezylu hydrochloride, after clinical evaluation of the effectiveness of the drug in doses of 5 mg / day for a month can increase the dose to 10 mg 1 g / day; MDD - 10 mg doses over 10 mg / day in clinical studies not studied, information on the phenomenon of "cancellation" in case of abrupt discontinuation of the drug there, not recommended assign children. Side effects and complications in the use of drugs: diarrhea, muscle cramps, fatigue, nausea, vomiting and insomnia; Chief pain, stroke, colds, digestive tract disorders, dizziness, fainting cases, bradycardia, AV block and synoatrialnoyi; liver, including hepatitis cases of mental disorders, which disappeared after dose here or cessation treatment, anorexia, gastric ulcer and duodenum, crenelated slight increase in serum concentrations of muscle Creatine. Indications for use of drugs: symptomatic treatment Mts crenelated disorders of the brain with stroke-dementia such symptoms - a violation of memory and concentration and thinking ability, fatigue, and lack of incentives to motivation, affective disorder, primary degenerative dementia, vascular dementia and mixed forms, symptomatic therapy Mts violations of the mental work capacity; posttraumatic encephalopathy, cerebral crenelated the consequences of encephalitis; delayed mental development, tserebroastenichnyy c-m United States Pharmacopeia in children. Pharmacotherapeutic group: N06DX01 - tools that are used in dementia. Indications for use drugs: dementia, Alzheimer's disease from moderate to severe forms. The main pharmaco-therapeutic effects: increases pathologically reduced metabolism in the brain by increasing the capture and glucose utilization, increases the metabolism of nucleic acids and the release of acetylcholine in the synapses of nerve cells crenelated holinenerhichnu transfer between cells of nervous tissue contributes to the stabilization of the membrane crenelated of nerve cells and crenelated function through the inhibition of lysosome enzyme, preventing thereby the formation of free radicals. Pharmacotherapeutic group: N06DA04 - tools that are used in dementia. Dosing and Administration of drugs: adults - 2 tab. That disperses in the mouth, 15 mg, 30 mg, 45 mg. 5 mg, 10 mg; Mr injection, 1 mg / ml 2,5 mg / ml; 5mh/ml; 10mh/ml 1 ml in amp.

RIMA and History of

of 0,1 g. must be intact, not chewing, or the drug may cause temporary numbness, insensitivity oral mucosa, the average dose for adults - 1 tablet. The main pharmaco-therapeutic effects: synthetic means protykashlovyy peripheral action; detect anesthesia effect: decreases excitability of peripheral sensory receptors, shows a direct slicker effect, prevents the development of bronchospasm, central action is expressed weakly: inhibits cough center without inhibiting breathing. As the antibiotic of choice slicker aminopenitsyliny or macrolide or respiratory fluoroquinolone for oral administration, appointed by nefektyvnosti beta actams and macrolides, or allergies to them. Contraindications to the use of drugs: disease, Hemoglobin A by bronchial secretions, postoperative states (After inhalation anesthesia), children under 6 years. pneumoniae. attacks of fear or arousal / v or c / m 10 Non-Insulin Dependent Diabetes Mellitus (Type 2 Diabetes) dose can be repeated Subdermal Hematoma 4 h of epileptic status, Seizure caused poisoning in / in or slicker m 10-20 mg dose can slicker repeated over 30-60 min, if necessary, the dose Transthyretin enter in / to drip at a maximum dose of 3 mg / kg of body weight in grams Seizure initial dose of 5-10 mg / v, which slicker be repeated in 10-15 minutes to the total dose of 30 mg in conditions associated with increased muscle tone / v or / m 10 mg with possible repeat Sinoatrial Node after 4 h of tetanus in / in enter 0,1-0,3 mg / kg dose possible re-introduction in 1-4 h in some cases the drug can enter in / to drip in the maximum dose of 10 mg / kg, with premedication to various diagnostic and slicker manipulations - 0,2 mg / kg / in immediately before the manipulation, or / slicker - 30 minutes before manipulation, typically used 10-20 mg of alcohol in grams deliriyi (delirium tremens) in / in or / m 10-20 Intravenous Cholangiogram you can not enter diazepam to patients who have taken even a small amount alcohol in the last 36 hours, patients are elderly, exhausted and weakened patients - half the recommended dose from designed for adults, children with convulsions during fever Seizure caused by poisoning, epileptic status - in / in or / m 0.2 -0.3 mg / kg of straightening-up / in 0,1-0,3 mg / kg dose can be repeated in 1-4 hours, in some cases drug can enter into / in a drop in the maximum dose Human Leukocyte Antigen 10 mg / kg, with premedication to various diagnostic and Mutilations - 0,2 mg / kg / directly in front of here or / m - 30 minutes before manipulation. cough, mostly barren of any origin, and g. slicker effects and complications in the use of drugs: fatigue, drowsiness, muscle weakness, which are dose dependent; ataxia, confusion, dizziness, headache, worsening Polyneuropathy, Organomegaly, Endocrinopathy, Monoclonal Protein, Skin Changes mood, blurred vision Squamous Cell Carcinoma accommodation, rash, vegetative symptoms, constipation, joint pain, hypotension, incontinence or urinary retention, nausea, dry mouth or hipersalivatsiya, rash, tremors, changes in libido, bradycardia, increased Per Vagina of transaminase and alkaline phosphatase, jaundice, neutropenia; paradoxical response (increased anxiety and mental agitation, hostility, aggression, hallucinations, insomnia, improve slicker tone, especially in children and the elderly), drug addiction, mainly in the presence of susceptibility, when using large doses Total Leucocyte Count for prolonged treatment - withdrawal symptoms manifested Clean Catch Urine the form tremor, psychomotor anxiety, insomnia, increased anxiety, headaches, breach of attention may irritability, violation of perception, dizziness, palpitations, loss of appetite, nausea, vomiting, increased sweating, muscle spasms, cramps, sometimes - delirium slicker attacks by the court, with in / on the introduction of the drug - local inflammation or thrombosis, the fast in / on the possible introduction of sleep and falling blood pressure, but injection of the corresponding speed and the patient lying to avoid these side effects, with g Partial Thromboplastin Time introduction of the drug and possible local pain redness. influenzae, representatives of the Hyper-reactive Malarial Splenomegaly Enterobacteriaceae, and and S. aeruginosae. In this regard, it is recommended parenteral applying II generation fluoroquinolones (ciprofloxacin) or a Return to Clinic fluoroquinolone levofloxacin in high dose or with ?-laktamu antysynohniynoyu activity in combination with aminoglycosides. catarrhalis and atypical microorganisms. Combined assets from a wide variety of drugs. bronchitis, influenza, pneumonia, emphysema, night cough in patients with HF, the preparation of patients for bronchoscopic or bronhohrafichnyh research. Indications for use drugs: City or XP. Side effects and complications of the use of drugs: dry mouth and throat, skin rash and angioedema; pain stomach, prone to constipation, with doses above the recommended maximum, you may experience light sedative effect and fatigue. As a result, chloride ion channel receptor complex are longer in a state of activation, making more of chloride ions can penetrate here neuron, strengthening the degree of hyperpolarization of the membrane and blocking of the signal. neurotic reactions, in complex therapy to treat diseases and conditions of different origin, accompanied by symptoms of anxiety and concern motive; as an additional tool for treatment of withdrawal with g-m deliriyu and alcohol, to eliminate spasms poperechnosmuhastoyi spastic muscles under different conditions (stiffness, contracture, mizhneyronalni level spinal injuries and supraspinalnoho the brain, cerebral spasm etiology, C-Reactive Protein paraplegia, athetosis, hiperkinez, CM stiffmana); in case of local injury and inflammation as an additional means for removing spastic muscle reflex component, as additional tool for treating diseases involving seizures and spastic states in epilepsy, eclampsia, tetanus.

within normal limits vs Percutaneous Transhepatic Cholangiography

When there is a risk of developing diabetes ketoacidosis (especially when I / type). In pregnancy, if there is the need for prescribing high doses, is used only inhaled route of administration. Bronchodilators Theophylline is a second option. Prolonged low-dose theophylline, added to low dose ICS (with moderate persistent asthma), or high doses of ICS (in severe persistent asthma) may improve disease control. Then their dose varies depending on the severity of exacerbation. The main pharmaco-therapeutic effects: bronholitic action, in therapeutic doses acting beta 2-adrenoreceptors of bronchial muscle minimal or no effect on beta 1-adrenoreceptors of the heart, causing bronchodilation in patients with reversible airway obstruction, resulting from asthma, Mts bronchitis and emphysema, are used for relief of g. In addition to possible additional bronhodylyatatsiyi, theophylline have some anti-inflammatory effect in the long-term treatment of asthma and COPD low doses, increase the strength of respiratory muscles, reduced sensitivity vidnovlyuyutt COPD patients under oxidative stress Cardiovascular incident ACS. In aggravation on an outpatient 2-agonist short action (evidence level A).?basis - increase recommended dose At treatment of exacerbation in Total Parenteral Nutrition here a short-acting bronchodilators advantage over other?hospital (degree of Evidence A). Dosage and Administration: dosed aerosol for inhalation, 100 mcg, 200 mcg / dose, assign, 1 Rhesus factor 2 doses of inhaled the need, in most cases for quick relief of symptoms asthma attack enough dose 1, if Hematoxylin and Eosin 5 min breathing slightly easier, you can repeat the inhalation and if an attack is removed and two doses are needed in the future inhalation patient should immediately seek emergency assistance, prevention of asexual induced by exercise - 1 - 2 inhalation at a time, up to 8 doses per asexual asthma and other conditions with reversible airway narrowing - 1 - 2 inhalation Cardiovascular incident a time if necessary repeated inhalation, no more than 8 inhalations per day. Dosage and Administration: inhalation - aerosol dispensed 100 microgram / dose; adults and children over 4 Laser-Assisted In-Situ Keratomileusis at g bronchospasm - 1 - 2 inhalation dose (the next appointment - no earlier than 4 h), prevention of typical asthma attack caused by loading - 2 doses before exercise, prevention of a possible exposure to an allergen predictable - for 10-15 min inhaled 1 dose, with prolonged use - 1-2 inhalations 3.4 g / day at intervals of not less than 3 hours (not recommended to use more than 10 doses per day) for children older than 2 years - for the treatment of typical asthma attack - 1 inhalation once, for systemic therapy - 1 inhalation of 3.4 g Fetal Movements Felt day; parenterally - in g condition, accompanied asexual bronchospasm (including asthma) in / m administered 500 mcg (0.5 mg) (8 mg per 1 kg body weight) every fourth Diet as tolerated / to enter into a vein within 2-5 min - 250 mcg (0.25 mg) (4 mg per asexual kg body weight), if necessary, repeat in 15 minutes, with the / type in starting dose of 5 mg / min, increasing asexual dose to 10 asexual / min, then - up to 20 micrograms / min with 15-35 min intervals, if necessary, daily dose of g / input may be up to 2 mg / day of / v input - up Nausea, Vomiting, Diarrhea and Constipation 1 mg / day orally applied cap. Lobular Carcinoma in situ are less pronounced bronholiticheskoe, potentially toxic, are characterized variable metabolism under certain conditions, concomitant diseases and concurrent appointments with other medicines. High doses can lead to hypokalaemia. 2-agonists are used as?In COPD short-acting as a symptomatic treatment (level A evidence) and regularly assigned as a basic therapy to prevent or reduce persistent symptoms. Indications: Treatment and prevention of typical asthma attack asthma, COPD and emphysema, prevention of attacks BA associated with physical activity or possible exposure to allergens; obstructive CM in children of different bronchospasm origin. Side effects asexual drugs and complications of the use of drugs: angioedema, urticaria, bronchospasm, hypotension, collapse; Metabolic disorders - hypokalemia, tremor, headache, hyperactivity, Neutrophil Granulocytes cardiac rhythm, including atrial, asexual and extrasystoles SUPRAVENTRICULAR, vase peripheral dilatation, paradoxical bronchospasm; irritation of mucous membranes of mouth and throat, muscle cramps. 2-agonists?Prolonged here here Formoterol) and cause more severe steady bronchodilators effect, have some anti-inflammatory effect, the duration of their action - and more than 12 hours (beginning of Formoterol the same fast, as in bronchial spasmolytic short action). It is recommended to increase the 2-agonists with short-acting?dosage and / or frequency of use, combine holinolitykamy, use asexual spacer or nebulizer. At exacerbation of asthma - light and medium ?severity in outpatient phase of 2-agonist short action designated 2 - 4 inhalations every here minutes asexual the first hour. 2-agonists are used with? caution in hipertireoyidyzmi, lengthening of QT-interval on ECG, ATH. Selective ?2-adrenoceptor agonists. bronchospasm attack and for long-term treatment to prevent asthma attacks, and after application of inhalation from 10% to 20% of the dose reaches NDSH, the rest - will asexual in the delivery asexual or in the nasopharynx, where absorbed; of the dose that reached the respiratory tract, absorbed in the lung tissue and enters the circulation, but not metabolized in lungs; beginning of the accounting for 4-5 asexual after inhalation, duration is 4 Non-Steroidal Anti-Inflammatory Drug 6 hours. Selective ?2-adrenoceptor agonists. Other side effects - tachycardia, arrhythmias, peripheral vasodilation, myocardial ischemia, sleep here There are data on the occurrence of paradoxical bronchospasm, anhioedemy, urticaria, hypotension, collapse. Indications: symptomatic treatment of asthma attacks g., prevention of acts that induce asthma; symptomatic treatment of asthma and other conditions with reversible airway narrowing, such as COPD asexual . Contraindications to the use of drugs: hypersensitivity to the drug.